European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

7 EU fundings (total €2,283,187): Gene Therapy for X-Linked Chronic Granulomatous Disease (CGD) … BdlYear 2012 Financial Transparency System

Text

District Court of Freiburg HRB 381757

01/02/2012 EU funding (€2,449,928): Pitn-GA-2011-289966-Bean Bean Bridging the European and Anatolian Neolithic: Demography, Migration, and Lifestyle AT the Advent of Civilization
01/11/2012 EU funding (€2,965,808): Systems Prediction of Chronic Lung Allograft Dysfunction
01/12/2012 EU funding (€3,582,048): Gene Therapy for X-Linked Chronic Granulomatous Disease (CGD)
01/11/2012 EU funding (€5,776,210): Epigenetics for Female Personalized Cancer Care
01/12/2012 EU funding (€645,513): Gene Therapy for X-Linked Chronic Granulomatous Disease (CGD)
01/12/2012 EU funding (€860,232): Gene Therapy for X-Linked Chronic Granulomatous Disease (CGD)
01/12/2012 EU funding (€911,813): Gene Therapy for X-Linked Chronic Granulomatous Disease (CGD)

DATA SERVICES

Unlock the full potential of processed company data with our API or Quarterly Exports.

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Eurofins Genomics Europe Pharma and Diagnostics Products & Services Sanger/PCR GmbH, Ebersberg, Germany.

Creative Commons License The visualizations for "7 EU fundings (total €2,283,187): Gene Therapy for X-Linked Chronic Granulomatous Disease (CGD) …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.